Feifei Wu

Title: Feifei Wu: Innovator in Hormone Preparation Technology

Introduction

Feifei Wu is a prominent inventor based in Nanjing, China. She has made significant contributions to the field of pharmaceutical technology, particularly in the preparation of high-purity adrenocorticotropic hormone (ACTH) analogues. Her innovative work has the potential to impact various medical applications.

Latest Patents

Feifei Wu holds a patent for a "High-purity adrenocorticotropic hormone analogue and a large-scale preparation method thereof." This patent describes polypeptide preparation methods for creating high-purity ACTH (human sequence) or its analogues. The main steps involve coupling amino acids from the C-terminal to the N-terminal using the Fmoc solid-phase synthesis method. The process yields a crude ACTH product, which is then purified through liquid chromatography, achieving a chromatographic purity of over 99% and a yield of ≥63%.

Career Highlights

Feifei Wu is associated with Nanjing Hanxin Pharmaceutical Technology Co., Ltd., where she applies her expertise in pharmaceutical innovations. Her work focuses on developing efficient methods for synthesizing hormones, which are crucial for various therapeutic applications.

Collaborations

Feifei Wu collaborates with notable colleagues, including Jundong Meng and Tao Yang. Their combined efforts contribute to advancing research and development in the pharmaceutical sector.

Conclusion

Feifei Wu's contributions to hormone preparation technology exemplify her innovative spirit and dedication to improving pharmaceutical processes. Her work not only enhances the quality of hormone preparations but also paves the way for future advancements in the field.